Cargando…
Prognostic factors for relapse in patients with clinical stage I testicular cancer: protocol for a Danish nationwide cohort study
INTRODUCTION: Approximately one-fourth of patients with clinical stage I testicular germ cell cancer will relapse within 5 years of follow-up. Certain histopathological features in the primary tumour have been associated with an increased risk of relapse. The available evidence on the prognostic val...
Autores principales: | Wagner, Thomas, Toft, Birgitte Grønkær, Engvad, Birte, Lauritsen, Jakob, Kreiberg, Michael, Bandak, Mikkel, Rosenvilde, Josephine, Christensen, Ib Jarle, Pilt, Anette Pedersen, Berney, Daniel, Daugaard, Gedske |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830695/ https://www.ncbi.nlm.nih.gov/pubmed/31676661 http://dx.doi.org/10.1136/bmjopen-2019-033713 |
Ejemplares similares
-
A Validated Algorithm for Register-Based Identification of Patients with Relapse of Clinical Stage I Testicular Cancer
por: Wagner, Thomas, et al.
Publicado: (2023) -
The Danish Testicular Cancer database
por: Daugaard, Gedske, et al.
Publicado: (2016) -
Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE)
por: Kreiberg, Michael, et al.
Publicado: (2018) -
A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)
por: Bandak, Mikkel, et al.
Publicado: (2017) -
Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer Patients
por: Garcia, Sara L, et al.
Publicado: (2020)